Now is the time to get involved and take advantage of the four largest assets for life science research and innovation of our region: MAX IV, ESS, DESY and European XFEL!
Welcome to Medicon Valley Alliance R&D Network and our 4th meeting!
Are you from the Biotech, Medtech, or Pharma industry or academia and are interested in learning how to make use of the largest assets we have in our region for life science innovation and research? Are you a regional development actor and representative from the health care system and wish to discuss how we can face the global challenges of improving health and healthcare solutions?
Medicon Valley Alliance (MVA), together with Hanseatic League of Science (HALOS), invites you to participate in MVA R&D network meeting on the 21st of November. Join the meeting and take the chance to learn more about how your organization can benefit from the large facilities! In addition to presentations from companies, facilities, academia, and funding stakeholders, the meeting will include a discussion forum and a networking session with posters from HALOS partner organizations. Now is the time to get involved in and be part of a new era for life science research and innovation in our region as well as globally.
|Date:||21 November, 2019|
|Time:||17:00 – 20:00|
|Host:||Hanseatic League of Science (HALOS)|
|Venue:||Medicon Village, Auditorium, Scheelevägen 2, 223 63 Lund|
HALOS is a newly started Öresund-Kattegat-Skagerack (ÖKS) interreg EU funded project with stakeholders from academia, regional development actors, research facilities and industry. HALOS will build a unique collaboration between Hamburg and South-West Scandinavia, bring together the four unique research facilities MAX IV, ESS, DESY and European XFEL, and create a centre for integrated, world-leading Life Science innovation and research.
MVA R&D Network is a professional and social network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in the hospital sector. The network focuses on best practice and current challenges for industry-academia collaboration and the commercialization of R&D in the Medicon Valley region.
The network is free of charge and is limited to Medicon Valley Alliance members. Non-member organizations and companies are welcome to attend one network event to evaluate whether joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically allow you to join the Medicon Valley Alliance R&D Network.
Will be contiounsly updated
Moderator: Anna Stenstam, CEO, CR Competence
|17.00 – 17.30||Registration, poster session, networking and a bite to eat|
|17.30 – 17.35||Welcome
Petter Hartman, CEO, Medicon Valley Alliance
Kajsa Paulsson, Project Manager, HALOS
|17.35 – 17.40||Patenting protein crystal structures – how and why (not)?
Peter Holm, Partner, European Patent Attorney, HØIBERG
Why & How – success stories, acces models (8-minute presentations)
Collaborations for increased utilization and capacity in industry
Transforming neutron and X-ray science to industrial innovation. Mission impossible?
MAX IV Laboratory for Life Science
AstraZeneca’s experiences in large scale facilities – tackle drug delivery challenges
Utilizing large scale facilities- examples from Novo Nordisk
3D structure determination in antibody drug development
Contract crystallography – how does it work
Data collection at synchrotrons
X-ray phase contrast zoom tomography as a novel tool to visualize human peripheral nerves
|19.10-19.30||Panel discussion/questions from the audience
How do we make the most of the facilities and what do YOU need to be able to get involved and take advantage of them?
Kajsa Paulsson, Project Manager , HALOS
|19.30 – 20.00||Networking, poster session & refreshments|
For more information please contact Senior Project Manager Helen Pettersson: email@example.com
|Host and sponsor|
|MVA R&D Network is managed by||In collaboration with|